Grant Private Wealth Management’s 10x Genomics TXG Stock Holding History

Grant Private Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Buy	+7,624	New	+$200K	0.12%	126
2026 Q1	–	Sell	-10,763	Closed	-$176K	–	161
2025 Q4	$176K	Sell	10,763 -1,290	-11%	-$19.5K	0.11%	133
2025 Q3	$141K	Buy	+12,053	New	+$157K	0.09%	141
2025 Q2	–	Sell	-13,638	Closed	-$119K	–	140
2025 Q1	$119K	Sell	13,638 -880	-6%	-$11.1K	0.13%	116
2024 Q4	$209K	Buy	+14,518	New	+$229K	0.23%	107

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grant Private Wealth Management's TXG Position: Q2 2026 in Review

Grant Private Wealth Management opened a new position in 10x Genomics (TXG) in Q2 2026: 7,624 shares worth $292K. The stake represents 0.12% of the portfolio and ranks #126 among its holdings. This is a return to the name: Grant Private Wealth Management previously reported a position in TXG as recently as Q4 2025.

Grant Private Wealth Management first reported a position in TXG in Q4 2024 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Grant Private Wealth Management held 7,624 shares of 10x Genomics worth $292K as of Q2 2026.
10x Genomics was a new Grant Private Wealth Management position in Q2 2026.
10x Genomics made up 0.12% of Grant Private Wealth Management's portfolio in Q2 2026, its #126 holding.
Grant Private Wealth Management first reported a position in 10x Genomics in Q4 2024 and has held it in 5 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Grant Private Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.